The new strategy of dydrogesterone protocol as progestin primed ovarian stimulation is effective for patients with ovarian endometriosis undergoing in vitro fertilization

This abstract describes a conference presentation evaluating the efficacy of dydrogesterone as a progestin priming agent in ovarian stimulation protocols for patients with ovarian endometriosis undergoing in vitro fertilization. The study compares this new strategy against standard methods to determine its effectiveness in improving fertility outcomes for this specific patient population. While the text confirms the focus on treating ovarian endometriosis, it provides no detailed results or statistical data within the provided snippet. This paper is centrally about endometriosis — specifically addressing treatment protocols for ovarian endometriosis during assisted reproductive technology.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works